Preclinical testing of a peptide-based, HER2/neu vaccine for prostate cancer.

Michael M. Woll, Matthew T. Hueman, Gayle B. Ryan, Constantin G. Ioannides, Charles G. Henderson, Isabelle A. Sesterhan, Shiv Shrivasta, David G. McLeod, Judd W. Moul, George E. Peoples

Research output: Contribution to journal › Article › peer-review